A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid
- PMID: 17315032
- DOI: 10.1038/ncpendmet0428
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid
Abstract
Papillary microcarcinoma of the thyroid (PMCT) is defined as papillary carcinoma measuring 1.0 cm or less. PCMT are frequently detected by ultrasonographic screening and ultrasonography-guided fine-needle aspiration biopsy. Although PMCT can pathologically show a high incidence of multifocality and lymph node metastasis in surgical specimens, most tumors grow slowly or not at all when they are monitored without surgery. In our observations only 6.7% of PMCT enlarged by 3.0 mm or more in diameter during 5 years of follow-up, and nodal metastases became detectable in 1.7% of patients overall. Observation without surgery could, therefore, be an attractive alternative for patients with low-risk PMCT; however, occult PMCT, which are diagnosed as the origin of lymph node or distant metastasis, show a worse prognosis. Even among incidentally detected PMCT, tumors with ultrasonographically detectable nodal metastasis are more likely to recur. Because such PMCT are most likely to recur in the regional lymph nodes, careful therapeutic neck dissection and total thyroidectomy are required. For incidentally detected and low-risk PMCT, careful observation without surgery might be acceptable, but careful and systematic surgery should be performed for patients with PMCT demonstrating aggressive characteristics.
Similar articles
-
Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroid.Expert Opin Pharmacother. 2007 Dec;8(18):3205-15. doi: 10.1517/14656566.8.18.3205. Expert Opin Pharmacother. 2007. PMID: 18035964 Review.
-
[Non-incidental papillary microcarcinomas of the thyroid].Medicina (B Aires). 2008;68(2):139-43. Medicina (B Aires). 2008. PMID: 18499963 Spanish.
-
Treatment for microcarcinoma of the thyroid--clinical experience.Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d. Clin Nucl Med. 2007. PMID: 17413573
-
[Papillary thyroid microcarcinoma].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009 Oct;26(5):1167-70. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009. PMID: 19947513 Review. Chinese.
-
Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.Ann Surg Oncol. 2009 Apr;16(4):920-8. doi: 10.1245/s10434-009-0332-9. Epub 2009 Feb 3. Ann Surg Oncol. 2009. PMID: 19189188
Cited by
-
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2. Thyroid. 2021. PMID: 33023426 Free PMC article. Review.
-
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.Endocrinol Metab (Seoul). 2024 Feb;39(1):47-60. doi: 10.3803/EnM.2024.1937. Epub 2024 Feb 15. Endocrinol Metab (Seoul). 2024. PMID: 38356210 Free PMC article. Review.
-
Routine Chest Computed Tomography at Presentation Does Not Identify Distant Metastasis in cT1aN0 Papillary Thyroid Carcinoma.Thyroid. 2020 Nov;30(11):1620-1624. doi: 10.1089/thy.2020.0073. Epub 2020 May 27. Thyroid. 2020. PMID: 32368954 Free PMC article.
-
Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?World J Surg. 2010 Jun;34(6):1291-3. doi: 10.1007/s00268-010-0469-5. World J Surg. 2010. PMID: 20162281 No abstract available.
-
Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area.World J Surg. 2010 Jun;34(6):1214-21. doi: 10.1007/s00268-009-0375-x. World J Surg. 2010. PMID: 20052467
Publication types
MeSH terms
LinkOut - more resources
Medical